
Nano-X Imaging (NNOX) Stock Forecast & Price Target
Nano-X Imaging (NNOX) Analyst Ratings
Bulls say
Nano X Imaging is positioned for success thanks to its partnerships with established distributors such as Digital X-Ray Imaging and its differentiated and cost-effective Nanox.ARC medical imaging system. Despite reporting a net loss in the prior year, the company continues to pursue growth and aims to generate $35 million in revenue by 2026. The steady cadence of distribution agreements demonstrates progress in building a national footprint, which could lead to strong revenue conversion depending on system placements, utilization rates, and reimbursement dynamics.
Bears say
Nano X Imaging is facing significant risks in the areas of clinical/regulatory, partnership/financial, commercial, legal/intellectual property, and market share. Despite showing improving top-line traction in their recent earnings report, the company is still in its early stages of commercialization, and has been weighed down by non-cash impairment and restructuring costs. The company's current focus is on expanding its U.S. distribution, but it will also need to execute on its rollout of Imperial Imaging, increase utilization of its imaging technology, and address regulatory limitations in order to improve its financial performance. Additionally, any changes in its capital structure or financing activities could significantly impact its near-term valuation.
This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.
Nano-X Imaging (NNOX) Analyst Forecast & Price Prediction
Start investing in Nano-X Imaging (NNOX)
Order type
Buy in
Order amount
Est. shares
0 shares